BLB&B Advisors LLC trimmed its position in shares of Bruker Co. (NASDAQ:BRKR – Free Report) by 4.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,440 shares of the medical research company’s stock after selling 186 shares during the […]
Pacer Advisors Inc. lifted its position in Bruker Co. (NASDAQ:BRKR – Free Report) by 747.0% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 20,759 shares of the medical research company’s stock after acquiring an additional 18,308 shares during the quarter. Pacer Advisors Inc.’s […]
Bruker Co. (NASDAQ:BRKR – Get Free Report) was the target of a significant increase in short interest during the month of August. As of August 31st, there was short interest totalling 4,090,000 shares, an increase of 8.2% from the August 15th total of 3,780,000 shares. Approximately 4.2% of the shares of the company are short […]
PhenomeX Inc. stock has more than doubled on Thursday after Bruker Corp. said it would acquire the Emeryville, Calif.-based, cell biology company for $1 a.